🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The study is being conducted to evaluate the efficacy and safety of convers...
Status
Completed
Location
Shandong Cancer Hospital and Institute
Start Date
2021-03-17
Trial ID
NCT05099848
Treatments Being Tested
This study is conducted to evaluate the efficacy, prognosis, adverse effect...
Status
Recruiting
Location
The Second Affiliated Hospital of Fujian Medical University
Start Date
2020-05-19
Trial ID
NCT05713994
This study was designed to evaluate the effectiveness and safety of hepatic...
Status
Unknown
Location
Sun Yat-sen University Cancer Center
Start Date
2022-06-15
Trial ID
NCT05313282
The purpose of this study is to evaluate the safety and efficacy of hepatic...
Status
Active Not Recruiting
Location
The first hospital of China medical university
Start Date
2024-08-16
Trial ID
NCT06632106
This study was designed to evaluate the effectiveness and safety of hepatic...
Status
Unknown
Location
Sun Yat-sen University Cancer Center
Start Date
2020-04-13
Trial ID
NCT04191889
Treatments Being Tested
To evaluate HAIC combined with Camrelizumab plus rivoceranib for advanced m...
Status
Recruiting
Location
Zhongshan Hospital, Fudan University
Start Date
2025-08-15
Trial ID
NCT07105748
Treatments Being Tested
Primary liver cancer is a malignant tumor with a very poor prognosis. Hepat...
Status
Not Yet Recruiting
Location
Zhejiang Cancer Hospital
Start Date
2027-09-01
Trial ID
NCT07691645
Treatments Being Tested
A Prospective, Single-Arm, Open-Label Clinical Study of the Efficacy and Sa...
Status
Not Yet Recruiting
Location
The First Affiliated Hospital of Zhengzhou University
Start Date
2026-08-30
Trial ID
NCT07790419
Treatments Being Tested
The purpose of this phase 2/3 study is to investigate the efficacy and safe...
Status
Recruiting
Location
Harbin Medical University Cancer Hospital
Start Date
2025-02-20
Trial ID
NCT06796803
Treatments Being Tested
This study aims to explore the value of the 'HAIC Apatinib Camrelizumab' tr...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-05-25
Trial ID
NCT07618546
Treatments Being Tested